Literature DB >> 29236125

[Laser treatment of basal cell carcinoma].

C Salavastru1,2, G S Tiplica3,4, K Fritz3,5.   

Abstract

With a clear increase in the incidence and a continuously earlier onset, the main risk factors for the development of basal cell carcinoma are still exposure to sunlight, fair skin, immunosuppression, carcinogens such as arsenic, chronic irritations and certain genodermatoses. Treatment options for localized resectionable basal cell carcinoma include micrographically controlled surgery, simple excision, curettage, laser ablation, cryosurgery, imiquimod, 5‑fluorouracil, photodynamic treatment and radiotherapy. Non-surgical treatment options are more suited for cases in which surgical procedures lead to disfigurement or functional impairments or for patients with a high surgical risk. Laser treatment, ablative and non-ablative as monotherapy or in combination can represent a meaningful treatment option in selected cases. In recent years there has been an increase in knowledge about the indications and effects of laser treatment of basal cell carcinoma; nevertheless, further studies with a high level of evidence are necessary.

Entities:  

Keywords:  Ablative laser treatment; Basal cell carcinoma; Combination treatment; Non-ablative laser treatment; Patient satisfaction

Mesh:

Year:  2018        PMID: 29236125     DOI: 10.1007/s00105-017-4092-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  38 in total

1.  Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted delivery of topical fluorouracil.

Authors:  Bichchau T Nguyen; Stephanie D Gan; Nellie Konnikov; Christine A Liang
Journal:  J Am Acad Dermatol       Date:  2015-03       Impact factor: 11.527

2.  Pulsed CO2 laser tissue ablation: measurement of the ablation rate.

Authors:  J T Walsh; T F Deutsch
Journal:  Lasers Surg Med       Date:  1988       Impact factor: 4.025

3.  The effect of pulsed dye laser on high-risk basal cell carcinomas with response control by Mohs micrographic surgery.

Authors:  Leticia Alonso-Castro; Luis Ríos-Buceta; Pablo Boixeda; John Paoli; Carmen Moreno; Pedro Jaén
Journal:  Lasers Med Sci       Date:  2014-10-31       Impact factor: 3.161

4.  Ultrapulse CO2 used for the successful treatment of basal cell carcinomas found in patients with basal cell nevus syndrome.

Authors:  Keyvan Nouri; Attica Chang; Jennifer T Trent; Gloria P Jiménez
Journal:  Dermatol Surg       Date:  2002-03       Impact factor: 3.398

5.  Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma.

Authors:  Z Apalla; A Lallas; T Tzellos; T Sidiropoulos; I Lefaki; M Trakatelli; E Sotiriou; E Lazaridou; G Evangelou; A Patsatsi; A Kyrgidis; A Stratigos; I Zalaudek; G Argenziano; D Ioannides
Journal:  Br J Dermatol       Date:  2014-04       Impact factor: 9.302

6.  Treatment of basal cell carcinoma with the pulsed carbon dioxide laser: a retrospective analysis.

Authors:  Shilesh Iyer; Leyda Bowes; Greg Kricorian; Andre Friedli; Richard E Fitzpatrick
Journal:  Dermatol Surg       Date:  2004-09       Impact factor: 3.398

7.  The effect of 595 nm pulsed dye laser on superficial and nodular basal cell carcinomas.

Authors:  Sonali M Shah; Nellie Konnikov; Lyn M Duncan; Zeina S Tannous
Journal:  Lasers Surg Med       Date:  2009-08       Impact factor: 4.025

8.  Confocal microscopy-guided laser ablation for superficial and early nodular Basal cell carcinoma: a promising surgical alternative for superficial skin cancers.

Authors:  Chih-Shan Jason Chen; Heidy Sierra; Miguel Cordova; Milind Rajadhyaksha
Journal:  JAMA Dermatol       Date:  2014-09       Impact factor: 10.282

9.  Fractionated laser resurfacing corrects the inappropriate UVB response in geriatric skin.

Authors:  Dan F Spandau; Davina A Lewis; Ally-Khan Somani; Jeffrey B Travers
Journal:  J Invest Dermatol       Date:  2012-03-01       Impact factor: 8.551

10.  Superpulsed CO 2 Laser with Intraoperative Pathologic Assessment for Treatment of Periorbital Basal Cell Carcinoma Involving Eyelash Line.

Authors:  Ali Ebrahimi; Mansour Rezaei; Reza Kavoussi; Mojtaba Eidizadeh; Seyed Hamid Madani; Hossein Kavoussi
Journal:  Dermatol Res Pract       Date:  2014-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.